Molecular epidemiology of Plasmodium vivax anti-folate resistance in India
Open Access
- 24 April 2011
- journal article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 10 (1), 102
- https://doi.org/10.1186/1475-2875-10-102
Abstract
Background: Sulphadoxine and pyrimethamine are anti-folate drugs that show synergistic anti-malarial effect. Point mutations in dihydrofolate reductase (dhfr) and dihydropteorate synthatase (dhps) cause anti-folate drug resistance phenotype in human malaria parasites. This study presents pattern of point mutations in dhfr/dhps genes among Indian sub-continent. Methods: Microscopically diagnosed one hundred Plasmodium vivax field isolates were collected from five widely separated geographical regions of India. Dhfr and dhps genes were PCR amplified and sequenced. Previously published mutations data were collected and analyzed using Chi square test to identify geographical cluster of mutant/wild type genotypes. Results: Sequence analysis revealed single (S58R), double (S58R/S117N) and quadruple (F57L/S58R/T61M/S117T/) point mutations at dhfr and single (A383G) to double (A383G/A553G) mutations at dhps in P. vivax field isolates. In addition, three new mutations were also observed at dhfr. Both, dhfr and dhps genes revealed tandem repeat variations in field isolates. Dhps revealed very low mutation frequency (14.0%) compared to dhfr (50.70%). Comparative analysis revealed a progressive increase in frequency of quadruple mutant dhfr genotype (p < 0.001) within five years in north-eastern state (Kamrup, Assam). Frequency of dhfr genotypes revealed three distinct geographical clusters of wild (northern India), double mutant (southern India), and quadruple mutant (north-eastern and island regions of India) on the Indian sub-continent. Conclusion: Study suggests that SP may be susceptible to P. vivax in India, except Andaman and north-eastern state. The distinction of geographical regions with sensitive and resistant parasite phenotypes would be highly useful for designing and administering national anti-malarial drug policy.Keywords
This publication has 41 references indexed in Scilit:
- Mutations in the Antifolate-Resistance-Associated Genes Dihydrofolate Reductase and Dihydropteroate Synthase in Plasmodium vivax Isolates from Malaria-Endemic CountriesThe American Journal of Tropical Medicine and Hygiene, 2010
- Severe Plasmodium vivax malaria exhibits marked inflammatory imbalanceMalaria Journal, 2010
- In Vitro Activity of Antifolate and Polymorphism in Dihydrofolate Reductase of Plasmodium falciparum Isolates from the Kenyan Coast: Emergence of Parasites with Ile-164-Leu MutationAntimicrobial Agents and Chemotherapy, 2009
- Linking HIV-Infected TB Patients to Cotrimoxazole Prophylaxis and Antiretroviral Treatment in IndiaPLOS ONE, 2009
- In Vivo and In Vitro Efficacy of Amodiaquine Monotherapy for Treatment of Infection by Chloroquine-Resistant Plasmodium vivaxAntimicrobial Agents and Chemotherapy, 2009
- Severe Vivax Malaria: Newly Recognised or Rediscovered?PLoS Medicine, 2008
- Multidrug-Resistant Plasmodium vivax Associated with Severe and Fatal Malaria: A Prospective Study in Papua, IndonesiaPLoS Medicine, 2008
- Plasmodium vivax and Mixed Infections Are Associated with Severe Malaria in Children: A Prospective Cohort Study from Papua New GuineaPLoS Medicine, 2008
- Determinants of In Vitro Drug Susceptibility Testing of Plasmodium vivaxAntimicrobial Agents and Chemotherapy, 2008
- Similar Trends of Pyrimethamine Resistance-Associated Mutations in Plasmodium vivax and P. falciparumAntimicrobial Agents and Chemotherapy, 2007